SK9242000A3 - Process for the preparation of paroxetine hydrochloride - Google Patents

Process for the preparation of paroxetine hydrochloride Download PDF

Info

Publication number
SK9242000A3
SK9242000A3 SK924-2000A SK9242000A SK9242000A3 SK 9242000 A3 SK9242000 A3 SK 9242000A3 SK 9242000 A SK9242000 A SK 9242000A SK 9242000 A3 SK9242000 A3 SK 9242000A3
Authority
SK
Slovakia
Prior art keywords
paroxetine hydrochloride
propan
solvate
preparation
paroxetine
Prior art date
Application number
SK924-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Alan David Jones
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK9242000A3 publication Critical patent/SK9242000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK924-2000A 1997-12-19 1998-12-18 Process for the preparation of paroxetine hydrochloride SK9242000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726907.0A GB9726907D0 (en) 1997-12-19 1997-12-19 Novel compounds
PCT/GB1998/003836 WO1999032484A1 (en) 1997-12-19 1998-12-18 Process for the preparation of paroxetine hydrochloride

Publications (1)

Publication Number Publication Date
SK9242000A3 true SK9242000A3 (en) 2001-01-18

Family

ID=10823933

Family Applications (1)

Application Number Title Priority Date Filing Date
SK924-2000A SK9242000A3 (en) 1997-12-19 1998-12-18 Process for the preparation of paroxetine hydrochloride

Country Status (20)

Country Link
EP (1) EP1042318A1 (zh)
JP (1) JP2001526288A (zh)
KR (1) KR20010033317A (zh)
CN (1) CN1281448A (zh)
AP (1) AP2000001836A0 (zh)
AU (1) AU1769899A (zh)
BG (1) BG104604A (zh)
BR (1) BR9813638A (zh)
CA (1) CA2315066A1 (zh)
EA (1) EA200000689A1 (zh)
GB (1) GB9726907D0 (zh)
HU (1) HUP0004503A3 (zh)
ID (1) ID24733A (zh)
IL (1) IL136590A0 (zh)
NO (1) NO20003145D0 (zh)
OA (1) OA11635A (zh)
PL (1) PL341358A1 (zh)
SK (1) SK9242000A3 (zh)
TR (1) TR200001933T2 (zh)
WO (1) WO1999032484A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
JP2005524656A (ja) * 2002-02-22 2005-08-18 テバ ファーマシューティカル インダストリーズ リミティド 新規中間物質を用いるパロキセチンの調製
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride

Also Published As

Publication number Publication date
EA200000689A1 (ru) 2000-12-25
IL136590A0 (en) 2001-06-14
NO20003145L (no) 2000-06-16
ID24733A (id) 2000-08-03
HUP0004503A2 (hu) 2002-03-28
PL341358A1 (en) 2001-04-09
AP2000001836A0 (en) 2000-06-30
JP2001526288A (ja) 2001-12-18
CA2315066A1 (en) 1999-07-01
AU1769899A (en) 1999-07-12
WO1999032484A1 (en) 1999-07-01
HUP0004503A3 (en) 2002-04-29
GB9726907D0 (en) 1998-02-18
EP1042318A1 (en) 2000-10-11
NO20003145D0 (no) 2000-06-16
BR9813638A (pt) 2000-10-17
TR200001933T2 (tr) 2000-12-21
BG104604A (en) 2001-03-30
KR20010033317A (ko) 2001-04-25
CN1281448A (zh) 2001-01-24
OA11635A (en) 2004-11-22

Similar Documents

Publication Publication Date Title
US5872132A (en) Form of paroxetine hydrochloride anhydrate
SK9242000A3 (en) Process for the preparation of paroxetine hydrochloride
EP1137636A1 (en) Process for preparation of paroxetine maleate
WO2000035910A1 (en) Derivative of paroxetine
EP1100796B1 (en) Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
WO2000032593A1 (en) Method of producing paroxetine hydrochloride
MXPA00006040A (en) Process for the preparation of paroxetine hydrochloride
CZ20002256A3 (cs) Způsob přípravy paroxetinhydrochloridu
EP1187830A1 (en) Process for the preparation of paroxetine and structurally related compounds
CA2323896A1 (en) Crystalline form of paroxetine
WO2001012623A1 (en) Process for the preparation of paroxetine hydrochloride
WO2001046148A1 (en) Novel processes
EP1155016A1 (en) Process for the production of paroxetine hydrochloride acetone solvate
US20020137938A1 (en) Novel process
EP1408039A2 (en) Mixed paraxetine propan-2-ol solvates
HU215599B (hu) Alfa-(4-klór-fenil)-4-[(4-fluor-fenil)-metil]-piperidin-1-etanol-észter-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
US20010008940A1 (en) Novel process
WO2000039122A1 (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
WO2000039121A1 (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
EP1140912A1 (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
WO2000078752A1 (en) Process for the production of paroxetine hydrochloride
WO2001012624A1 (en) Paroxetine
EP1133492A1 (en) Process for the preparation of paroxetine hydrochloride